Literature DB >> 27317516

Thalidomide and lenalidomide for the treatment of refractory dermatologic conditions.

Zachary Nahmias1, Vinod E Nambudiri2, Ruth Ann Vleugels3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27317516     DOI： 10.1016/j.jaad.2016.03.022

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  1 in total

1.  Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment.

Authors:  Stephen P Erickson; Zachary Nahmias; Ilana S Rosman; Kara Sternhell-Blackwell; Amy C Musiek
Journal:  JAAD Case Rep       Date:  2018-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.